Sweden
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
40.21%
|
Dec. 31, 2023 | USD 0.45 | -1.52% |
|
Sweden |
|
2 |
39.71%
|
Dec. 31, 2023 | USD 21.91 | 3.49% |
|
Sweden |
|
3 |
30.60%
|
Dec. 31, 2023 | USD 19.20 | -5.48% |
|
Sweden |
|
4 |
27.12%
|
Dec. 31, 2023 | USD 3.64 | -2.31% |
|
Sweden |
|
5 |
18.50%
|
Dec. 31, 2024 | USD 3.53 | -1.01% |
|
Sweden |
|
6 |
17.96%
|
Dec. 31, 2023 | USD 2.53 | -0.42% |
|
Sweden |
|
7 |
17.84%
|
Dec. 31, 2023 | USD 4.96 | -3.19% |
|
Sweden |
|
8 |
10.89%
|
Dec. 31, 2023 | USD 2.02 | -4.42% |
|
Sweden |
|
9 |
10.55%
|
Dec. 31, 2023 | USD 2.27 | -2.64% |
|
Sweden |
|
10 |
10.24%
|
Dec. 31, 2023 | USD 0.18 | -1.59% |
|
Sweden |
|
11 |
6.20%
|
Dec. 31, 2023 | USD 0.22 | -4.95% |
|
Sweden |
|
12 |
3.13%
|
Dec. 31, 2023 | USD 0.43 | -0.29% |
|
Sweden |
|
13 |
-4.62%
|
Dec. 31, 2023 | USD 0.27 | -2.38% |
|
Sweden |
|
14 |
-17.75%
|
Dec. 31, 2023 | USD 0.16 | -2.74% |
|
Sweden |
|
15 |
-22.10%
|
April 30, 2024 | USD 0.13 | -1.11% |
|
Sweden |
|
16 |
-61.61%
|
Dec. 31, 2023 | USD 0.67 | -3.68% |
|
Sweden |
|
17 |
-90.69%
|
Dec. 31, 2023 | USD 19.80 | -1.20% |
|
Sweden |
|
18 |
-332.33%
|
Dec. 31, 2023 | USD 0.50 | -2.16% |
|
Sweden |
|
19 |
-693.80%
|
Dec. 31, 2023 | USD 0.09 | -2.04% |
|
Sweden |
The Telehealth company in Sweden with the highest EBITDA Margin is ContextVision AB (publ) (Oslo Stock Exchange: CONTX.OL) at 40.21%.
The Telehealth company in Sweden with the lowest EBITDA Margin is Scandinavian ChemoTech AB (publ) (Stockholm Stock Exchange: CMOTEC-B.ST) at -693.80%.
The top 10 Telehealth companies in Sweden by EBITDA Margin are ContextVision AB (publ), RaySearch Laboratories AB (publ), CellaVision AB (publ), Sleep Cycle AB (publ), Arjo AB (publ), Careium AB (Publ), Bahnhof AB (publ), Sinch AB (publ), Mentice AB (publ) and Clavister Holding AB (publ.).
The bottom 10 Telehealth companies in Sweden by EBITDA Margin are Scandinavian ChemoTech AB (publ), Senzime AB (publ), Vitrolife AB (publ), Compodium International AB (publ), ScandiDos AB (publ), Ortivus AB (publ), Medhelp Care Aktiebolag (publ), Hedera Group AB (publ), Kontigo Care AB (publ) and Clavister Holding AB (publ.).